|
|
Volumn 42, Issue 3, 1978, Pages 1129-1134
|
|
Clinical research on the treatment of locally advanced lung cancer. Final report of VALG protocol 13 limited
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOXORUBICIN;
HYDROXYUREA;
LOMUSTINE;
ADENOCARCINOMA;
ADVERSE DRUG REACTION;
BLOOD AND HEMOPOIETIC SYSTEM;
BONE MARROW DEPRESSION;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMPARISON;
DUODENUM ULCER;
ESOPHAGITIS;
ESOPHAGUS;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG CANCER;
LUNG CARCINOMA;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
RADIOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY SYSTEM;
SMALL CELL CARCINOMA;
THERAPY;
ADENOCARCINOMA;
BONE MARROW;
CARCINOMA, SMALL CELL;
CARCINOMA, SQUAMOUS CELL;
CLINICAL TRIALS;
COMPARATIVE STUDY;
DOSE-RESPONSE RELATIONSHIP, RADIATION;
DOXORUBICIN;
DRUG THERAPY, COMBINATION;
ESOPHAGITIS;
HUMAN;
HYDROXYUREA;
LOMUSTINE;
LUNG NEOPLASMS;
MALE;
NITROSOUREA COMPOUNDS;
RADIATION INJURIES;
RADIOTHERAPY, HIGH-ENERGY;
REMISSION, SPONTANEOUS;
TIME FACTORS;
|
|
EID: 0018073129
PISSN: 0008543X
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/1097-0142(197809)42:3<1129::AID-CNCR2820420315>3.0.CO;2-F Document Type: Article |
|
Times cited : (31)
|
|
References (19)
|
